Xolair 150 MG/ML autoinjectorml
Ended Awarded
- Contract number
- SPE2DX25F6XTM
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $6,849
Award facts
- Contract value 100% obligated
- $6,848.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $6,848.88 on September 17, 2025, for the supply of Xolair 150 mg/ml auto-injectors. This firm fixed-price delivery order, which has an ultimate completion date of October 8, 2025, was issued without a set-aside designation and is funded by the Defense Logistics Agency's Medical Supply Chain division. The award represents a continuation of the company's role as a critical supplier within the federal pharmaceutical supply chain, leveraging its established indefinite delivery contract with DLA under the SPE2DB program, valued at $499,999,999 through November 2026.
DMS Pharmaceutical Group's portfolio demonstrates extensive experience distributing branded and generic pharmaceuticals, biologics, and medical consumables to Department of Defense healthcare facilities nationwide. The company's track record includes delivery orders for specialized pharmaceutical products ranging from oncology treatments to immunology medications and medical devices. This particular delivery order for Xolair, a monoclonal antibody used primarily for severe asthma and chronic urticaria treatment, underscores the vendor's capability to supply specialized injectable medications to military and federal healthcare systems. The performance location in Park Ridge, Illinois serves as the distribution hub for fulfilling this and similar supply orders to support DoD medical operations.
Quick answers
Who was awarded contract SPE2DX25F6XTM?
SPE2DX25F6XTM was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on September 17, 2025.
How much is contract SPE2DX25F6XTM worth?
The government has obligated $6,849 on SPE2DX25F6XTM.
Is contract SPE2DX25F6XTM an order under another contract?
Yes. SPE2DX25F6XTM is a delivery order under SPE2DX15D9168, an indefinite delivery contract.
Was contract SPE2DX25F6XTM competed?
The extent of competition for SPE2DX25F6XTM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award